Pages that link to "Q54301077"

The following pages link to Neurotrophic action of VIP on spinal cord cultures. (Q54301077):

Displaying 41 items.

• Automated image analysis for counting unstained cultured neurones (Q33264349) (← links)
• VIP neuroprotection against excitotoxic lesions of the developing mouse brain (Q33838449) (← links)
• Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis (Q35295564) (← links)
• Vasoactive intestinal peptide and electrical activity influence neuronal survival (Q35591566) (← links)
• Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide (Q36216272) (← links)
• Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent (Q37351335) (← links)
• A femtomolar-acting neuroprotective peptide (Q37355041) (← links)
• Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain (Q37370085) (← links)
• Acquired immune deficiency syndrome and the developing nervous system (Q37612294) (← links)
• VIP-induced neuroprotection of the developing brain (Q37869518) (← links)
• Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation (Q38303183) (← links)
• VIP: molecular biology and neurobiological function (Q38776643) (← links)
• VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment (Q40423132) (← links)
• PACAP functions as a neurotrophic factor (Q40511653) (← links)
• Neuropeptides as growth and differentiation factors in general and VIP in particular (Q40819326) (← links)
• Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin? (Q41271887) (← links)
• Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide (Q41478941) (← links)
• Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos (Q41926156) (← links)
• Growth factor properties of VIP during early brain development. Whole embryo culture and in vivo studies (Q41927127) (← links)
• Vasoactive intestinal peptide influences neurite outgrowth in cultured rat spinal cord neurons (Q43836214) (← links)
• Lipopolysaccharide induces cell death in cultured porcine myenteric neurons. (Q46679821) (← links)
• Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury. (Q47892585) (← links)
• Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). (Q48243100) (← links)
• VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide (Q48295184) (← links)
• Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease (Q48627726) (← links)
• Growth of the early postimplantation embryo. Regulation by high-affinity, GTP-insensitive VIP receptors (Q48725415) (← links)
• Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity (Q48727057) (← links)
• Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain (Q48831323) (← links)
• VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury (Q48916561) (← links)
• Organization of vasoactive intestinal peptide-like immunoreactive system in the brain, olfactory organ and retina of the zebrafish, Danio rerio, during development (Q49097866) (← links)
• VIP and PACAP 38 modulate ibotenate-induced neuronal heterotopias in the newborn hamster neocortex (Q49115803) (← links)
• A quantitative study of neuropeptide immunoreactive cell bodies of primary afferent sensory neurons following rat sciatic nerve peripheral axotomy (Q50802458) (← links)
• Protection against developmental deficiencies by a lipophilic VIP analogue. (Q52039654) (← links)
• Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. (Q52121112) (← links)
• Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos (Q59058656) (← links)
• Distribution of vasoactive intestinal peptide-like immunoreactivity in the brain and pituitary of the frog (Rana esculenta) during development (Q60506586) (← links)
• Chapter II Brain PACAP/VIP receptors: regional distribution, functional properties and physiological relevance (Q61774069) (← links)
• Screening of adrenal medullary neuropeptides for putative neurotrophic effects (Q68210303) (← links)
• Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity (Q73484920) (← links)
• Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway (Q73770795) (← links)
• [Vasoactive intestinal peptide: a novel neurotrophic factor] (Q77365708) (← links)